This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Venditti, F. J. Articles by Bowen, S. Search for Related Content PubMed PubMed Citation Articles by Venditti, F. J., Jr Articles by Bowen, S.

Circulation, Vol 89, 216-223, Copyright © 1994 by American Heart Association

ARTICLES

Rise in chronic defibrillation thresholds in nonthoracotomy implantable defibrillator

FJ Venditti Jr, DT Martin, G Vassolas and S Bowen
Cardiac Electrophysiology Laboratory, Lahey Clinic Medical Center, Burlington, Mass. 01805.

BACKGROUND: To establish the chronic stability of defibrillation thresholds (DFTs) in a transvenous cardioverter/defibrillator (TCD) system, we studied 37 consecutive patients with TCD systems implanted for > 6 months. METHODS AND RESULTS: DFT was measured by a step-down method at implant and 2 and 6 months later. The mean ejection fraction was 34.5 +/- 14.3%. Coronary artery disease with previous myocardial infarction was present in 31 patients. The mean DFT rose from 13.3 +/- 4.3 J at implant to 16.5 +/- 4.7 J at 2 months (P < .001) and 17.6 +/- 5.4 J at 6 months (P < .0001). ANOVA revealed a statistically significant rise in DFT over time (P < .0005). At 2 months, 25 patients had a rise in DFT, and 14 had a rise > or = 5 J. The observed rise at 2 months persisted in 19 patients. A chronic rise, defined as > or = 5 J rise at 6 months, occurred in 17 patients. Univariate analysis of clinical as well as implant variables revealed no predictors of a rise in DFT in this group. CONCLUSIONS: We conclude that there is a significant rise in DFT at 2 and 6 months in this TCD system. Although the chronic threshold remained well within the available energy range of the pulse generator, this observation has important implications for implantation guidelines, programming, and future pulse generator development for TCD patients.

This article has been cited by other articles:

				S. H. Hohnloser, P. Dorian, R. Roberts, M. Gent, C. W. Israel, E. Fain, J. Champagne, and S. J. Connolly Effect of Amiodarone and Sotalol on Ventricular Defibrillation Threshold: The Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Trial Circulation, July 11, 2006; 114(2): 104 - 109. [Abstract] [Full Text] [PDF]

				E. J. Rashba, M. R. Olsovsky, S. R. Shorofsky, M. M. Kirk, R. W. Peters, and M. R. Gold Temporal decline in defibrillation thresholds with an active pectoral lead system J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1150 - 1155. [Abstract] [Full Text] [PDF]

				S. Windecker, R. E. Ideker, V. J. Plumb, G. N. Kay, G. P. Walcott, and A. E. Epstein The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in humans J. Am. Coll. Cardiol., January 1, 1999; 33(1): 33 - 38. [Abstract] [Full Text] [PDF]

				A. E. Epstein, G. N. Kay, V. J. Plumb, S. M. Dailey, and P. G. Anderson Gross and Microscopic Pathological Changes Associated With Nonthoracotomy Implantable Defibrillator Leads Circulation, October 13, 1998; 98(15): 1517 - 1524. [Abstract] [Full Text] [PDF]

				D. Newman, A. Barr, M. Greene, D. Martin, M. Ham, S. Thorne, and P. Dorian A Population-Based Method for the Estimation of Defibrillation Energy Requirements in Humans : Assessment of Time-Dependent Effects With a Transvenous Defibrillation System Circulation, July 1, 1997; 96(1): 267 - 273. [Abstract] [Full Text]

				A. Pacifico, K. R. Wheelan, N. Nasir, P. J. Wells, T. K. Doyle, S. A. Johnson, and P. D. Henry Long-term Follow-up of Cardioverter-Defibrillator Implanted Under Conscious Sedation in Prepectoral Subfascial Position Circulation, February 18, 1997; 95(4): 946 - 950. [Abstract] [Full Text]

				F. J. Venditti, R. M. John, M. Hull, G. H. Tofler, D. M. Shahian, and D. T. Martin Circadian Variation in Defibrillation Energy Requirements Circulation, October 1, 1996; 94(7): 1607 - 1612. [Abstract] [Full Text]

				D. M. Shahian, W. A. Williamson, L. G. Svensson, R. S. D'Agostino, D. T. Martin, J. R. Ellis, and F. J. Venditti Transvenous versus transthoracic cardioverter-defibrillator implantation: A comparative analysis of morbidity, mortality, and survival J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1066 - 1074. [Abstract] [Full Text]

				M. R. Gold, S. Higgins, R. Klein, F. R. Gilliam, H. Kopelman, S. Hessen, J. Payne, S. A. Strickberger, D. Breiter, and S. Hahn Efficacy and Temporal Stability of Reduced Safety Margins for Ventricular Defibrillation: Primary Results From the Low Energy Safety Study (LESS) Circulation, April 30, 2002; 105(17): 2043 - 2048. [Abstract] [Full Text] [PDF]